Journal of Endocrinology and Metabolism, ISSN 1923-2861 print, 1923-287X online, Open Access
Article copyright, the authors; Journal compilation copyright, J Endocrinol Metab and Elmer Press Inc
Journal website

Case Report

Volume 12, Number 3, June 2022, pages 111-115

Hypocalcemia After the Administration of Denosumab in a Patient With Osteoporotic Fracture and Vitamin D Deficiency


Figure 1.
Figure 1. Serum corrected calcium and phosphorus levels in a patient with hypocalcemia after denosumab therapy. D-110 means 110 days before denosumab was administered and serum calcium was normal. D0 means the day when denosumab was administered, and serum calcium was not checked on D0, so there is no “D0” in the figure. D5 is the first day when low serum calcium was noticed after denosumab administration.